T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival.
McHugh
Lynsey A
LA
Griffiths
Thomas R L
TR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000209:etiology; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine